Finding 1173939 (2023-007)

Material Weakness Repeat Finding
Requirement
M
Questioned Costs
-
Year
2023
Accepted
2026-02-17
Audit: 387535
Organization: National Indian Health Board (DC)
Auditor: SIKICH CPA LLC

AI Summary

  • Core Issue: Lack of proper monitoring of subrecipients, leading to missing documentation for compliance with federal requirements.
  • Impacted Requirements: Failure to verify subrecipient eligibility, conduct site visits, and maintain necessary documentation as outlined in 2 CFR 200.232.
  • Recommended Follow-Up: Implement annual checks for suspension/debarment, obtain annual audited financial statements, and enhance monitoring policies to ensure compliance.

Finding Text

Improper monitoring of subrecipients 93.011 National Organizations for State and Local Officials 93.318 Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security 93.421 Strengthening Public Health Systems and Services Criteria: 2 CFR 200.232 states “A pass through entity must: (a) Verify that the subrecipient is not excluded or disqualified in accordance with 180.300. Verification methods are provided in 180.300, which include confirming in SAM.gov that a potential subrecipient is not suspended, debarred, or otherwise excluded from receiving Federal funds; (e) Monitor the activities of a subrecipient as necessary to ensure that the subrecipient complied with Federal statutes, regulations, and the terms and conditions of the subaward. The pass through entity is responsible for monitoring the overall performance of a subrecipient to ensure that the goals and objectives of the subaward are achieved. In monitoring a subrecipient, a pass through entity must: (1) Review financial and performance reports. (2) Ensure that the subrecipient takes corrective action on all significant developments that negatively affect the subaward. Significant developments include Single Audit findings related to the subaward, other audit findings, site visits, and written notifications from a subrecipient of adverse conditions which will impact their ability to meet the milestones or the objectives of a subaward. When significant development negatively impact the subaward, a subrecipient must provide the pass through entity with information on their plan for corrective action and any assistance needed to resolve the situation. (3) Issue a management decision for audit findings pertaining only to the Federal ward provided to the subrecipient from the pass through entity as required by 200.521.(4) Resolve audit findings specifically related to the subaward. However, the pass through entity is not responsible for resolving cross cutting audit findings that apply the subaward and other Federal awards or subawards. If a subrecipient has a current Single Audit report and has not been excluded from receiving Federal funding (meaning, has not been debarred or suspended), the pass through entity may rely on the subrecipient’s cognizant agency for audit or oversight agency for audit to perform audit follow up and make management decisions related to cross cutting audit findings in accordance with section 200.513(a)(4)(viii). Such reliance does not eliminate the responsibility of the pass through entity to issue subawards that confirm to agency and award specific requirements, to manage risk through ongoing subaward monitoring, and to monitor the status of the findings that are specifically related to the subaward. (f) Depending up on the pass through entity’s assessment of the risk posed by the subrecipient, the following monitoring tools may be useful for the pass through entity to ensure proper accountability and compliance with program requirements and achievement of performance goals: (1) Providing subrecipients with training and technical assistance on program related matters; (2) Performing site visits to review the subrecipient’s program operations; and (3) Arranging for agreed upon procedures engagements as described in 200.425.” Condition: Auditors noted there was no documentary evidence of the following subrecipient monitoring requirements: obtain budgets for reasonable expenses from subrecipients, SAM.gov suspension and debarment check, site visit documentation, receiving updated audit reports from subrecipients and issuing management decisions over federal award findings for pass through entities. We consider this condition to be a material weakness to the Subrecipient Monitoring compliance requirement and is a repeat finding shown in Section IV of this report as prior year finding 2022 007. Statistical sampling was not used in making sample selections. Questioned costs: None Effect: As a result, the Organization was missing documentation relating to subrecipient monitoring requirements for the year ended December 31, 2023. Cause: This is due to ineffective controls over subrecipient monitoring resulting in a lack of documentation, miscommunications during employee transitions and the need to train new employees on policies and procedures. Recommendation: Auditors recommend that there are checks at least annually for suspension or debarment and that documentation be maintained for all checks completed. In addition the Organization should follow up and obtain audited financial statements each year from subrecipients and issue management decisions for federal award findings for pass through entities. It is also recommended to improve subrecipient monitoring policies so subrecipient budgets are received as well as site visits conducted of subrecipients. It is critical that subrecipients are properly monitored to ensure that they are complying with Uniform Guidance requirements. Views of Responsible Officials and Planned Corrective Actions: Management agrees with this Single Audit Finding and response is included in the Corrective Action Plan.

Corrective Action Plan

In response to the findings on subrecipient monitoring, the Organization has updated its Grant Cycle Standard Operating Procedures to align with OMB Uniform Guidance. These revised procedures now require documented checks for suspension or debarment for all subrecipients, along with mandated follow-up on any subrecipient audit findings. In addition, staff have received enhanced training on these requirements, and the onboarding process has been updated to include a focused review of subrecipient monitoring. Finally, a new position has been established to manage vendor purchase orders and maintain comprehensive sourcing documentation, thereby strengthening overall oversight and ensuring ongoing compliance with federal requirements. In addition, the Organization conducts an annual subrecipient risk assessment and maintains a monitoring file for each subrecipient that includes audit reviews, SAM.gov verifications, monitoring communications, and follow-up on audit findings. Documentation is retained to demonstrate ongoing monitoring.

Categories

Subrecipient Monitoring Procurement, Suspension & Debarment

Other Findings in this Audit

  • 1173851 2023-005
    Material Weakness Repeat
  • 1173852 2023-006
    Material Weakness Repeat
  • 1173853 2023-007
    Material Weakness Repeat
  • 1173854 2023-008
    Material Weakness Repeat
  • 1173855 2023-004
    Material Weakness Repeat
  • 1173856 2023-005
    Material Weakness Repeat
  • 1173857 2023-006
    Material Weakness Repeat
  • 1173858 2023-007
    Material Weakness Repeat
  • 1173859 2023-008
    Material Weakness Repeat
  • 1173860 2023-004
    Material Weakness Repeat
  • 1173861 2023-005
    Material Weakness Repeat
  • 1173862 2023-006
    Material Weakness Repeat
  • 1173863 2023-007
    Material Weakness Repeat
  • 1173864 2023-008
    Material Weakness Repeat
  • 1173865 2023-004
    Material Weakness Repeat
  • 1173866 2023-005
    Material Weakness Repeat
  • 1173867 2023-006
    Material Weakness Repeat
  • 1173868 2023-007
    Material Weakness Repeat
  • 1173869 2023-008
    Material Weakness Repeat
  • 1173870 2023-004
    Material Weakness Repeat
  • 1173871 2023-005
    Material Weakness Repeat
  • 1173872 2023-006
    Material Weakness Repeat
  • 1173873 2023-007
    Material Weakness Repeat
  • 1173874 2023-008
    Material Weakness Repeat
  • 1173875 2023-004
    Material Weakness Repeat
  • 1173876 2023-005
    Material Weakness Repeat
  • 1173877 2023-006
    Material Weakness Repeat
  • 1173878 2023-007
    Material Weakness Repeat
  • 1173879 2023-008
    Material Weakness Repeat
  • 1173880 2023-004
    Material Weakness Repeat
  • 1173881 2023-005
    Material Weakness Repeat
  • 1173882 2023-006
    Material Weakness Repeat
  • 1173883 2023-007
    Material Weakness Repeat
  • 1173884 2023-008
    Material Weakness Repeat
  • 1173885 2023-004
    Material Weakness Repeat
  • 1173886 2023-005
    Material Weakness Repeat
  • 1173887 2023-006
    Material Weakness Repeat
  • 1173888 2023-007
    Material Weakness Repeat
  • 1173889 2023-008
    Material Weakness Repeat
  • 1173890 2023-004
    Material Weakness Repeat
  • 1173891 2023-005
    Material Weakness Repeat
  • 1173892 2023-006
    Material Weakness Repeat
  • 1173893 2023-007
    Material Weakness Repeat
  • 1173894 2023-008
    Material Weakness Repeat
  • 1173895 2023-004
    Material Weakness Repeat
  • 1173896 2023-005
    Material Weakness Repeat
  • 1173897 2023-006
    Material Weakness Repeat
  • 1173898 2023-007
    Material Weakness Repeat
  • 1173899 2023-008
    Material Weakness Repeat
  • 1173900 2023-004
    Material Weakness Repeat
  • 1173901 2023-005
    Material Weakness Repeat
  • 1173902 2023-006
    Material Weakness Repeat
  • 1173903 2023-007
    Material Weakness Repeat
  • 1173904 2023-008
    Material Weakness Repeat
  • 1173905 2023-004
    Material Weakness Repeat
  • 1173906 2023-005
    Material Weakness Repeat
  • 1173907 2023-006
    Material Weakness Repeat
  • 1173908 2023-007
    Material Weakness Repeat
  • 1173909 2023-008
    Material Weakness Repeat
  • 1173910 2023-004
    Material Weakness Repeat
  • 1173911 2023-005
    Material Weakness Repeat
  • 1173912 2023-006
    Material Weakness Repeat
  • 1173913 2023-007
    Material Weakness Repeat
  • 1173914 2023-008
    Material Weakness Repeat
  • 1173915 2023-004
    Material Weakness Repeat
  • 1173916 2023-005
    Material Weakness Repeat
  • 1173917 2023-006
    Material Weakness Repeat
  • 1173918 2023-007
    Material Weakness Repeat
  • 1173919 2023-008
    Material Weakness Repeat
  • 1173920 2023-005
    Material Weakness Repeat
  • 1173921 2023-006
    Material Weakness Repeat
  • 1173922 2023-008
    Material Weakness Repeat
  • 1173923 2023-005
    Material Weakness Repeat
  • 1173924 2023-006
    Material Weakness Repeat
  • 1173925 2023-008
    Material Weakness Repeat
  • 1173926 2023-004
    Material Weakness Repeat
  • 1173927 2023-005
    Material Weakness Repeat
  • 1173928 2023-006
    Material Weakness Repeat
  • 1173929 2023-007
    Material Weakness Repeat
  • 1173930 2023-008
    Material Weakness Repeat
  • 1173931 2023-004
    Material Weakness Repeat
  • 1173932 2023-005
    Material Weakness Repeat
  • 1173933 2023-006
    Material Weakness Repeat
  • 1173934 2023-007
    Material Weakness Repeat
  • 1173935 2023-008
    Material Weakness Repeat
  • 1173936 2023-004
    Material Weakness Repeat
  • 1173937 2023-005
    Material Weakness Repeat
  • 1173938 2023-006
    Material Weakness Repeat
  • 1173940 2023-008
    Material Weakness Repeat

Programs in Audit

ALN Program Name Expenditures
93.341 ANALYSES, RESEARCH AND STUDIES TO ADDRESS THE IMPACT OF CMS’ PROGRAMS ON AMERICAN INDIAN/ALASKA NATIVE (AI/AN) BENEFICIARIES AND THE HEALTH CARE SYSTEM SERVING THESE BENEFICIARIES $804,408
93.011 NATIONAL ORGANIZATIONS FOR STATE AND LOCAL OFFICIALS $498,838
66.309 SURVEYS, STUDIES, INVESTIGATIONS, TRAINING AND SPECIAL PURPOSE ACTIVITIES RELATING TO ENVIRONMENTAL JUSTICE $467,089
93.421 STRENGTHENING PUBLIC HEALTH SYSTEMS AND SERVICES THROUGH NATIONAL PARTNERSHIPS TO IMPROVE AND PROTECT THE NATION’S HEALTH $101,462
93.318 PROTECTING AND IMPROVING HEALTH GLOBALLY: BUILDING AND STRENGTHENING PUBLIC HEALTH IMPACT, SYSTEMS, CAPACITY AND SECURITY $100,994
93.933 DEMONSTRATION PROJECTS FOR INDIAN HEALTH $83,041